Tag: IIb
Bone therapeutics: Failure of a phase IIb trial in fractures
Read also (CercleFinance.com) – The Biosenic study dedicated to the healing of difficult fractures gave negative results, thus leading to a suspension of the trial, announced Monday the biotechnology company.…
Bone Therapeutics Introduces Interim Analysis in Phase IIb ALLOB Study
By Arnaud Bives Published on 07/15/2022 at 07:55 (Boursier.com) — Bone…
Inventiva receives a €4 million milestone payment from AbbVie following the launch of the Phase IIb study with cedirogant – 01/31/2022 at 22:00
Daix (France), Long Island City (New York), United States, January 31, 2022 – Inventiva SA (“Inventiva” or the “Company”) (Euronext Paris and Nasdaq: IVA), a biopharmaceutical company specializing in the…
Inventiva receives a €4 million milestone payment from AbbVie following the launch of the Phase IIb study with cedirogant – 01/31/2022 at 22:00
Daix (France), Long Island City (New York), United States January 31, 2022 – Inventiva SA (“Inventiva” or the “Company”) (Euronext Paris and Nasdaq: IVA), a biopharmaceutical company specializing in the…